Cargando…
Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials
BACKGROUND: Current guidelines recommend newer generation drug-eluting stents (DES) over bare-metal stents (BMS) in patients with ischemic heart disease. However, there is no age-specific recommendation in elderly patients. METHODS: Meta-analysis was performed of 6 randomized studies enrolling 5,042...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078958/ https://www.ncbi.nlm.nih.gov/pubmed/31702046 http://dx.doi.org/10.5603/CJ.a2019.0109 |
_version_ | 1783685136456351744 |
---|---|
author | Bae, SungA Kim, Yongcheol Gogas, Bill D. Kim, Min Chul Sim, Doo Sun Hong, Young Joon Kim, Ju Han Ahn, Youngkeun Jeong, Myung Ho |
author_facet | Bae, SungA Kim, Yongcheol Gogas, Bill D. Kim, Min Chul Sim, Doo Sun Hong, Young Joon Kim, Ju Han Ahn, Youngkeun Jeong, Myung Ho |
author_sort | Bae, SungA |
collection | PubMed |
description | BACKGROUND: Current guidelines recommend newer generation drug-eluting stents (DES) over bare-metal stents (BMS) in patients with ischemic heart disease. However, there is no age-specific recommendation in elderly patients. METHODS: Meta-analysis was performed of 6 randomized studies enrolling 5,042 elderly patients who underwent percutaneous coronary intervention (PCI) with stent implantation (DES, n = 2,579; BMS, n = 2,463). RESULTS: Combined data indicated a significant reduction in major adverse cardiovascular events (MACEs) with use of DES (odds ratio [OR] 0.56, 95% confidence interval [CI] 0.44–0.71, p < 0.001). Moreover, use of DES was associated with a significantly lower incidence of myocardial infarction (OR 0.54, 95% CI 0.36–0.81, p = 0.003) and repeat revascularization (OR 0.44, 95% CI 0.31–0.62, p < 0.001), was compared to that with the use of BMS. Stent thrombosis and bleeding complication rates were not significantly different between groups. In a subgroup meta-analysis, short duration (1 or 6 months) dual antiplatelet therapy (DAPT) was associated with a significantly lower MACE rate (OR 0.49, 95% CI 0.34–0.80; p = 0.003) in elderly patients who underwent PCI with everolimus-eluting stent implantation, compared with that using long duration DAPT. CONCLUSIONS: This meta-analysis provides clinically relevant evidence that DES rather than BMS should be selected for elderly patients. |
format | Online Article Text |
id | pubmed-8078958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Via Medica |
record_format | MEDLINE/PubMed |
spelling | pubmed-80789582021-05-10 Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials Bae, SungA Kim, Yongcheol Gogas, Bill D. Kim, Min Chul Sim, Doo Sun Hong, Young Joon Kim, Ju Han Ahn, Youngkeun Jeong, Myung Ho Cardiol J Interventional Cardiology BACKGROUND: Current guidelines recommend newer generation drug-eluting stents (DES) over bare-metal stents (BMS) in patients with ischemic heart disease. However, there is no age-specific recommendation in elderly patients. METHODS: Meta-analysis was performed of 6 randomized studies enrolling 5,042 elderly patients who underwent percutaneous coronary intervention (PCI) with stent implantation (DES, n = 2,579; BMS, n = 2,463). RESULTS: Combined data indicated a significant reduction in major adverse cardiovascular events (MACEs) with use of DES (odds ratio [OR] 0.56, 95% confidence interval [CI] 0.44–0.71, p < 0.001). Moreover, use of DES was associated with a significantly lower incidence of myocardial infarction (OR 0.54, 95% CI 0.36–0.81, p = 0.003) and repeat revascularization (OR 0.44, 95% CI 0.31–0.62, p < 0.001), was compared to that with the use of BMS. Stent thrombosis and bleeding complication rates were not significantly different between groups. In a subgroup meta-analysis, short duration (1 or 6 months) dual antiplatelet therapy (DAPT) was associated with a significantly lower MACE rate (OR 0.49, 95% CI 0.34–0.80; p = 0.003) in elderly patients who underwent PCI with everolimus-eluting stent implantation, compared with that using long duration DAPT. CONCLUSIONS: This meta-analysis provides clinically relevant evidence that DES rather than BMS should be selected for elderly patients. Via Medica 2021-04-13 /pmc/articles/PMC8078958/ /pubmed/31702046 http://dx.doi.org/10.5603/CJ.a2019.0109 Text en Copyright © 2021 Via Medica https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. |
spellingShingle | Interventional Cardiology Bae, SungA Kim, Yongcheol Gogas, Bill D. Kim, Min Chul Sim, Doo Sun Hong, Young Joon Kim, Ju Han Ahn, Youngkeun Jeong, Myung Ho Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials |
title | Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials |
title_full | Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials |
title_fullStr | Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials |
title_full_unstemmed | Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials |
title_short | Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials |
title_sort | efficacy and safety of drug-eluting stents in elderly patients: a meta-analysis of randomized trials |
topic | Interventional Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078958/ https://www.ncbi.nlm.nih.gov/pubmed/31702046 http://dx.doi.org/10.5603/CJ.a2019.0109 |
work_keys_str_mv | AT baesunga efficacyandsafetyofdrugelutingstentsinelderlypatientsametaanalysisofrandomizedtrials AT kimyongcheol efficacyandsafetyofdrugelutingstentsinelderlypatientsametaanalysisofrandomizedtrials AT gogasbilld efficacyandsafetyofdrugelutingstentsinelderlypatientsametaanalysisofrandomizedtrials AT kimminchul efficacyandsafetyofdrugelutingstentsinelderlypatientsametaanalysisofrandomizedtrials AT simdoosun efficacyandsafetyofdrugelutingstentsinelderlypatientsametaanalysisofrandomizedtrials AT hongyoungjoon efficacyandsafetyofdrugelutingstentsinelderlypatientsametaanalysisofrandomizedtrials AT kimjuhan efficacyandsafetyofdrugelutingstentsinelderlypatientsametaanalysisofrandomizedtrials AT ahnyoungkeun efficacyandsafetyofdrugelutingstentsinelderlypatientsametaanalysisofrandomizedtrials AT jeongmyungho efficacyandsafetyofdrugelutingstentsinelderlypatientsametaanalysisofrandomizedtrials |